Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms TQB3126 |
Target |
Action degraders |
Mechanism ERs degraders(Estrogen receptors degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Phase 2 | China | 17 Jul 2026 | |
| Advanced breast cancer | IND Approval | China | 06 Jul 2026 |





